Investors Purchase High Volume of Put Options on ARK Genomic Revolution ETF (BATS:ARKG)

ARK Genomic Revolution ETF (BATS:ARKG) was the target of some unusual options trading on Friday. Stock traders bought 15,452 put options on the company. This is an increase of approximately 50% compared to the typical volume of 10,321 put options.

ARK Genomic Revolution ETF Trading Up 5.8 %

ARKG traded up $1.37 during trading on Friday, hitting $24.83. 4,932,711 shares of the company’s stock traded hands. The business’s 50-day moving average is $24.97 and its 200 day moving average is $27.61.

Hedge Funds Weigh In On ARK Genomic Revolution ETF

A number of institutional investors and hedge funds have recently modified their holdings of ARKG. BNP Paribas Financial Markets raised its holdings in ARK Genomic Revolution ETF by 101.5% in the 1st quarter. BNP Paribas Financial Markets now owns 2,330,573 shares of the company’s stock worth $67,027,000 after purchasing an additional 1,173,872 shares during the period. Goldman Sachs Group Inc. raised its holdings in ARK Genomic Revolution ETF by 271.4% in the 4th quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock worth $21,090,000 after purchasing an additional 469,740 shares during the period. SG Americas Securities LLC raised its holdings in ARK Genomic Revolution ETF by 835.6% in the 4th quarter. SG Americas Securities LLC now owns 213,059 shares of the company’s stock worth $6,990,000 after purchasing an additional 190,287 shares during the period. Clearwater Capital Advisors LLC raised its holdings in ARK Genomic Revolution ETF by 3.8% in the 1st quarter. Clearwater Capital Advisors LLC now owns 173,759 shares of the company’s stock worth $4,997,000 after purchasing an additional 6,385 shares during the period. Finally, Cetera Investment Advisers raised its holdings in ARK Genomic Revolution ETF by 290.7% during the first quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock valued at $4,052,000 after acquiring an additional 104,831 shares during the period.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.